Genflow Biosciences PLC Announces Result of AGM

About this update from Genflow Biosciences Plc

LONDON, UK / ACCESS Newswire / June 29, 2026 / Genflow Biosciences Plc (LSE:GENF)(OTCQB:GENFF) ("Genflow" or "the Company") an emerging leader in the field of longevity research, is pleased to announce that all resolutions proposed at the Annual General Meeting held earlier today were duly passed by shareholders. The number of proxy votes for each resolution submitted prior to the meeting are presented below.Proxy Voting ResultsOrdinary ResolutionsVotes for% of votes cast forVotes Against% of votes cast againstTotal votes castVotes withheld1. To receive and consider the Annual Report and Accounts for the year ended 31 December 2025 together with the Directors' Report and Auditors' Report thereon.102,370,02899.94%56,8930.06%102,426,9211,0582. To approve the directors' remuneration report for the financial period ended 31 December 2025 set out in the audited accounts for the financial period ended 31 December 2025.102,348,30599.92%78,6160.08%102,426,9211,0583. To re-appoint PKF Littlejohn LLP as auditors of the Company and to authorise the Directors of the Company to fix their remuneration.102,370,09499.94%56,6030.06%102,426,6971,2824. To re-elect Gad Berdugo as a Director of the Company.102,363,74999.93%64,0060.07%102,427,7552245. To re-elect Dr Eric Leire as a Director of the Company.102,363,55799.93%64,1980.07%102,427,7552246. To re-elect Tamara Joseph as a Director of the Company.102,363,55799.93%64,1980.07%102,427,7552247. To re-elect Dr Yassine Bendiabdallah as a Director of the Company.102,363,45999.70%64,2960.30%102,427,7552248. To re-elect Guy-Charles Fanneau De La Horie as a Director of the Company.102,363,45999.70%64,2960.30%102,427,7552249. To approve the adoption of the share option scheme (the "Scheme") by the Company.101,237,55498.86%1,162,0311.13%102,399,58528,39410. To authorise the Directors of the Company to allot shares for the Scheme Options (up to 14.34%)101,264,43498.86%1,162,3211.14%102,426,4651,22411. To authorise the Directors of the Company to allot shares (up to 33%)101,264,72498.86%1,162,0311.14%102,426,7551,224Special ResolutionVotes for% of votes cast forVotes Against% of votes cast againstTotal votes castVotes withheld12. To disapply statutory pre-emption rights in respect of Resolution 10 (Scheme Options)101,218,85298.82%1,208,1271.18%102,426,9791,00013. To disapply statutory pre-emption rights in respect of Resolution 11101...

View stock analysis, news, and events for Genflow Biosciences Plc